Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22612517
Conclusion of this study
In conclusion, our study supports the hypothesis that MYO administration is more effective in obese patients with high fasting insulin plasma levels.
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
 Digestive System |
 Endocrine System |
